A Dublin- based company has won a contract to make sunscreen coating for a satellite. Enbio is the one, which has been awarded with a €500,000 worth contract from European Space Agency.
It has been said that the company has to make black surface, so that there are no apprehensions among agency officials when they have to send satellites to the sun. The project will get launched in 2017, revealed sources known to the matter.
The European Space Agency (ESA) said that they will be launching the satellite to the sun in 2017. For which, Enbio will be setting up a manufacturing facility at NovaUCD to develop the coating.
Once the coating gets developed, it will be used on the Solar Orbiter satellite. It is said that the satellite will be travelling closer to the sun and is said to be the first satellite to try the same.
"The challenges of building a spacecraft that will fly so close to the Sun means we are always looking at better ways to protect it from the harsh environment", said Andy Whitehouse, who is the manager at the Solar Orbiter programme.
Nigel Cobbe, who is the, vice-president at Enbio, said that they are quite excited about their new project.
In a recent announcement, Twitter has said that it is launching a new companion app – called ‘Engage’ – to enable its users to know the people who are following their campaigns and activity on the popular microblogging platform.
Announcing...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
First human trial of a potential Zika vaccine has...
Managing sleep should now become easier with the launch...
Google lacks when anyone searches for a health problem...
In a Monday announcement, Chinese device maker Huawei...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).